Phibro Animal Health Corp (NASDAQ:PAHC) COO Larry Lee Miller sold 14,182 shares of the stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $35.49, for a total value of $503,319.18. Following the completion of the sale, the chief operating officer now owns 8,582 shares of the company’s stock, valued at $304,575.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Larry Lee Miller also recently made the following trade(s):
- On Tuesday, February 13th, Larry Lee Miller sold 54,572 shares of Phibro Animal Health stock. The shares were sold at an average price of $35.36, for a total value of $1,929,665.92.
Shares of Phibro Animal Health Corp (NASDAQ PAHC) traded down $0.40 during mid-day trading on Tuesday, hitting $35.05. The stock had a trading volume of 109,103 shares, compared to its average volume of 80,197. The company has a quick ratio of 1.75, a current ratio of 3.12 and a debt-to-equity ratio of 1.82. The firm has a market capitalization of $1,428.79, a price-to-earnings ratio of 22.91, a PEG ratio of 2.52 and a beta of 1.18. Phibro Animal Health Corp has a fifty-two week low of $26.70 and a fifty-two week high of $40.25.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 28th. Stockholders of record on Wednesday, March 7th will be issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date is Tuesday, March 6th. Phibro Animal Health’s dividend payout ratio is presently 26.14%.
A number of equities research analysts have commented on PAHC shares. Zacks Investment Research upgraded Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Monday, January 8th. BidaskClub cut Phibro Animal Health from a “sell” rating to a “strong sell” rating in a research note on Friday, December 29th. Credit Suisse Group increased their price target on Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a research note on Tuesday, February 6th. ValuEngine cut Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th. Finally, Piper Jaffray Companies reiterated a “buy” rating and issued a $42.00 price target on shares of Phibro Animal Health in a research note on Friday, November 10th. Three analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $38.20.
Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Phibro Animal Health by 3.0% in the second quarter. Vanguard Group Inc. now owns 1,780,880 shares of the company’s stock valued at $65,982,000 after purchasing an additional 51,474 shares during the period. Copper Rock Capital Partners LLC increased its holdings in shares of Phibro Animal Health by 9.6% in the fourth quarter. Copper Rock Capital Partners LLC now owns 631,876 shares of the company’s stock valued at $21,326,000 after purchasing an additional 55,235 shares during the period. FMR LLC increased its holdings in shares of Phibro Animal Health by 31.9% in the second quarter. FMR LLC now owns 584,463 shares of the company’s stock valued at $21,654,000 after purchasing an additional 141,274 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Phibro Animal Health by 11.8% in the third quarter. Dimensional Fund Advisors LP now owns 465,297 shares of the company’s stock valued at $17,239,000 after purchasing an additional 49,296 shares during the period. Finally, Renaissance Technologies LLC increased its holdings in shares of Phibro Animal Health by 16.4% in the fourth quarter. Renaissance Technologies LLC now owns 463,496 shares of the company’s stock valued at $15,527,000 after purchasing an additional 65,396 shares during the period. 48.42% of the stock is currently owned by institutional investors and hedge funds.
WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.americanbankingnews.com/2018/02/13/insider-selling-phibro-animal-health-corp-pahc-coo-sells-14182-shares-of-stock.html.
About Phibro Animal Health
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.